Table 1.
Sample characteristics (independent variables): Baseline
| Variables |
TOTAL (n = 44) |
Men (n = 32) |
Women (n = 12) |
P |
|---|---|---|---|---|
| Socio-demographic variables | ||||
| - Age (years) | 49.2 (11.9) | 50.7 (10.1) | 45 (15.5) | 0.897 |
| - Legal representative | ||||
| • No | 36 (81.8%) | 28 (63.8%) | 8 (18.2%) | 0.185 |
| • Yes | 8 (18.2%) | 4 (9.1%) | 4 (9.1%) | |
| - Household composition | ||||
| • Individual | 12 (27.3%) | 10 (22.8%) | 2 (4.5%) | 0.285 |
| • Horizontal | 3 (6.8%) | 1 (2.3%) | 2 (4.5%) | |
| • Complete | 3 (6.8%) | 3 (6.8%) | 0 (0%) | |
| • Own family home | 7 (15.9%) | 4 (9.1%) | 3 (6.8%) | |
| • Other: Supervised flat | 19 (43.2%) | 14 (31.8%) | 5 (11.4%) | |
| - Economic level | ||||
| • High | 6 (13.6%) | 5 (11.4%) | 1 (2.3%) | 0.754 |
| • Medium | 26 (59.1%) | 19 (43.2%) | 7 (15.9%) | |
| • Low | 12 (27.3%) | 8 (18.2%) | 4 (9.1%) | |
| - Level of education | ||||
| • Uneducated | 4 (9.1%) | 3 (6.8%) | 1 (2.3%) | 0.009 |
| • Primary | 19 (43.2%) | 9 (20.5%) | 10 (22.7%) | |
| • Secondary | 17 (38.6%) | 16 (36.4%) | 1 (2.3%) | |
| • University | 4 (9.1%) | 4 (9.1%) | 0 (0%) | |
| - Area of residence | ||||
| • Urban | 38 (86.4%) | 29 (65.9%) | 9 (20.5%) | 0.321 |
| • Rural | 6 (13.6%) | 3 (6.8%) | 3 (6.8%) | |
| Clinical Variables | ||||
| -Psychiatric diagnosis | ||||
| • Schizophrenia | 37 (84.1%) | 26 (59.1%) | 11 (25%) | 0.608 |
| • Schizoaffective Disorder | 5 (11.4%) | 4 (9.1%) | 1 (2.3%) | |
| • Delusional Disorder | 2 (4.5%) | 2 (4.5%) | 0 (0%) | |
| - Duration of illness (years) | 21.6 (12.4) | 22.4 (11) | 16.6 (15.9) | 0.715 |
| - Age at first hospitalisation (years) | 31.4 (11) | 30.7 (10.8) | 33.2 (11.5) | 0.572 |
| - Consumption of toxics | ||||
| • No | 15 (34.1%) | 9 (20.5%) | 6 (13.6%) | 0.284 |
| • Yes | 29 (65.9%) | 23 (52.3%) | 6 (13.6%) | |
| - Type of toxics | ||||
| • Alcohol | 6 (13.6%) | 5 (11.3%) | 1 (2.3%) | 1.00 |
| • Tobacco | 29 (65.9%) | 23 (52.3%) | 6 (13.6%) | |
| • Cocaine | 3 (6.8%) | 2 (4.5%) | 1 (2.3%) | |
| • Opioids | 2 (4.5%) | 1 (2.3%) | 1 (2.3%) | |
| • Amphetamines | 3 (6.8%) | 2 (4.5%) | 1 (2.3%) | |
| • Cannabis | 10 (22.7%) | 7 (15.9%) | 3 (6.8%) | |
| - Cardio-metabolic diagnosis | ||||
| • No | 24 (54.5%) | 15 (34.1%) | 9 (20.5%) | 0.095 |
| • Yes | 20 (45.5%) | 17 (38.6%) | 3 (6.8%) | |
| - Type Cardio-metabolic diagnosis | ||||
| • AHT | 10 (22.7%) | 8 (18.2%) | 2 (4.5%) | 0.059 |
| • DM | 7 (15.9%) | 5 (11.4%) | 2 (4.5%) | |
| • Hyperlipemia | 14 (31.8%) | 13 (29.6%) | 1 (2.2%) | |
| Therapeutic Variables | ||||
| - Reason for Change: Antipsychotic Treatment | ||||
| • Unchanged | 31 (70.5%) | 20 (45.5%) | 11 (25%) | 0.302 |
| • Lack of efficiency | 5 (11.4%) | 5 (11.4%) | 0 (9.1%) | |
| • Tolerability/safety issues | 2 (4.5%) | 1 (2.3%) | 1 (2.3%) | |
| • Patient's own choice | 3 (6.8%) | 1 (2.3%) | 2 (4.5%) | |
| • Other: Clinical improvement | 3 (6.8%) | 2 (4.5%) | 1 (2.3%) | |
AHT Arterial hypertension, DM diabetes mellitus